tiprankstipranks
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market
TARS
Tarsus Pharmaceuticals
RESEARCH TOOLSreports

Tarsus Pharmaceuticals (TARS) Income Statement

266 Followers

Tarsus Pharmaceuticals Income Statement

Last quarter (Q4 2025), Tarsus Pharmaceuticals's total revenue was $151.67M, an increase of 128.39% from the same quarter last year. In Q4, Tarsus Pharmaceuticals's net income was $-8.37M. See Tarsus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 451.36M$ 182.95M$ 17.45M$ 25.82M$ 57.03M
Gross Profit
$ 420.68M$ 170.13M$ 15.85M$ 24.86M$ 54.95M
Operating Expenses
$ 491.64M$ 290.70M$ 159.01M$ 87.57M$ 67.11M
Depreciation and Amortization
$ 1.82M$ 1.23M$ 877.00K$ 326.00K$ 312.00K
EBITDA
$ -53.61M$ -106.48M$ -131.67M$ -59.70M$ -13.46M
Operating Income
$ -70.97M$ -120.57M$ -143.16M$ -62.71M$ -12.16M
Other Income/Expenses
$ 6.61M$ 5.01M$ 7.26M$ 617.00K$ -1.61M
Pretax Income
$ -64.36M$ -115.55M$ -135.89M$ -62.09M$ -13.77M
Net Income
$ -66.42M$ -115.55M$ -135.89M$ -62.09M$ -13.83M
Per Share Metrics
Basic EPS
$ -1.59$ -3.07$ -4.62$ -2.52$ -0.67
Diluted EPS
$ -1.59$ -3.07$ -4.62$ -2.52$ -0.67
Weighted Average Shares Outstanding
 41.78M 37.60M 29.38M 24.62M 20.55M
Weighted Average Shares Outstanding (Diluted)
 41.78M 37.60M 29.38M 24.62M 20.55M
Currency in USD

Tarsus Pharmaceuticals Earnings and Revenue History